NCT05205096View on ClinicalTrials.gov

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

June 3, 2022

Study Completion Date

July 31, 2022

Conditions

COVID-19

Interventions

BIOLOGICAL

Recombinant novel coronavirus vaccine (CHO cells)

At 3-9 months after the immunization with 2 doses of inactivated vaccine (CoronaVac), 1 dose of recombinant novel coronavirus vaccine (CHO cells) is vaccinated.

Trial Locations (1)

310051

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou

All Listed Sponsors

collaborator

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT05205096 - Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac | Biotech Hunter | Biotech Hunter